Despite weak revenue forecasts, Bio-Thera Solutions' high P/S ratio shows investor optimism. However, revenue growth could impact share price. With a weak revenue outlook, share price may decline, affecting P/S figures. Investors should be cautious.

Despite a high P/S ratio, the company's growth rates are limited. Investors may face disappointment if the P/S falls in line with recent growth rates. The high P/S ratio may not be justified given recent performance.

Bio-Thera Solutions maintains strong finances but loss at EBIT level and fall in revenue indicate future risks. The company's financial developments need monitoring due to these risks.